首页> 外文期刊>The Journal of Pathology: Clinical Research >Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype?¢????genotype correlation
【24h】

Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype?¢????genotype correlation

机译:根据WHO实体,临床参数和表型,基因型相关性对结肠锯齿状前体病变的炎症反应进行分类

获取原文
       

摘要

Abstract Studies on traditional serrated adenoma (TSA) and sessile serrated adenoma with dysplasia (SSA-D) are rare due to the low frequency of these lesions, which are well defined by the latest WHO classification. However, introducing new morphological criteria such as intra-epithelial lymphocytes (IELs) might facilitate colorectal polyp diagnoses. Additionally, the phenotype?¢????genotype correlation needs to be updated as the terminology has repeatedly changed. This study analysed 516 polyps, consisting of 118 classical adenomas (CAD), 116 hyperplastic polyps (HPP), 179 SSAs, 41 SSA-Ds, and 62 TSAs. The lesions were analysed in relation to the patients?¢???? clinical parameters including gender, age, localisation, and size. The inflammatory background of the polyps was quantified and BRAF and KRAS mutations as well as MLH1 and CDKN2A promoter methylation were assessed. In multivariate analyses, an increase in IELs was an independent and robust new criterion for the diagnosis of SSA-D ( p < 0.001). Superficial erosions and acute neutrophil granulocytes led to reactive changes potentially resembling dysplasia. KRAS and BRAF mutations were associated with CAD/TSA and HPP/SSA, respectively. However, almost half of TSAs had a BRAF mutation and were KRAS wild type. CDKN2A seems to precede MLH1 hyper-methylation within the serrated carcinogenesis model. The genotyping of WHO-based entities ?¢???? and especially SSA ?¢???? has sharpened in comparison to previously published data. TSAs can be sub-grouped according to their mutation status. Of note, the higher number of IELs in SSA-D reflects their close relationship to colorectal cancers with micro-satellite instability. Therefore, IELs might represent a new diagnostic tool for SSA-D.
机译:摘要传统的锯齿状腺瘤(TSA)和无固定型锯齿状腺瘤伴异型增生(SSA-D)的研究很少,因为这些病灶的发生频率较低,这在最新的WHO分类中已得到很好的定义。但是,引入新的形态学标准,例如上皮内淋巴细胞(IEL),可能有助于大肠息肉的诊断。另外,由于术语已经反复改变,所以需要更新表型与基因型的相关性。本研究分析了516例息肉,包括118例经典腺瘤(CAD),116例增生性息肉(HPP),179例SSA,41例SSA-D和62例TSAs。分析了与患者有关的病变?临床参数包括性别,年龄,位置和大小。量化息肉的炎症背景,评估BRAF和KRAS突变以及MLH1和CDKN2A启动子甲基化。在多变量分析中,IEL的升高是诊断SSA-D的独立且可靠的新标准(p <0.001)。浅表糜烂和急性中性粒细胞粒细胞导致反应性改变,可能类似于发育异常。 KRAS和BRAF突变分别与CAD / TSA和HPP / SSA相关。然而,几乎一半的TSA具有BRAF突变并且是KRAS野生型。在锯齿状致癌模型中,CDKN2A似乎先于MLH1高甲基化。世卫组织实体的基因分型特别是SSA?¢ ????与以前发布的数据相比,已有所提高。 TSA可以根据其突变状态进行分组。值得注意的是,SSA-D中较高的IEL数量反映了它们与具有微卫星不稳定性的结直肠癌的密切关系。因此,IEL可能代表了SSA-D的新诊断工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号